Jagsonpal Pharmaceuticals Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jagsonpal Pharmaceuticals Limited has announced a board meeting on April 8, 2025, to discuss a certificate received from MCS Share Transfer Agent Limited regarding compliance with SEBI regulations for the quarter ended March 31, 2025. The certificate confirms that securities submitted for dematerialization have been listed on stock exchanges, and relevant records have been updated accordingly. This update reflects the company’s commitment to regulatory compliance, which may bolster investor confidence. The adherence to such regulations typically points to operational stability, although investors should monitor any broader market implications moving forward.